CN1209805A - 新型稠合的吡咯碳酰胺、新一类的gaba脑受体配位体 - Google Patents

新型稠合的吡咯碳酰胺、新一类的gaba脑受体配位体 Download PDF

Info

Publication number
CN1209805A
CN1209805A CN97191759A CN97191759A CN1209805A CN 1209805 A CN1209805 A CN 1209805A CN 97191759 A CN97191759 A CN 97191759A CN 97191759 A CN97191759 A CN 97191759A CN 1209805 A CN1209805 A CN 1209805A
Authority
CN
China
Prior art keywords
compound
oxygen
carboxamide
indoles
tetrahydrochysene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97191759A
Other languages
English (en)
Chinese (zh)
Inventor
帕梅拉·阿尔鲍格
刘刚
肯尼斯·肖
阿兰·哈奇森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurogen Corp
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of CN1209805A publication Critical patent/CN1209805A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
CN97191759A 1996-01-19 1997-01-14 新型稠合的吡咯碳酰胺、新一类的gaba脑受体配位体 Pending CN1209805A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/588,711 1996-01-19
US08/588,711 US5804686A (en) 1996-01-19 1996-01-19 fused pyrrolecarboxamides; a new class of GABA brain receptor ligands

Publications (1)

Publication Number Publication Date
CN1209805A true CN1209805A (zh) 1999-03-03

Family

ID=24354983

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97191759A Pending CN1209805A (zh) 1996-01-19 1997-01-14 新型稠合的吡咯碳酰胺、新一类的gaba脑受体配位体

Country Status (26)

Country Link
US (2) US5804686A (enExample)
EP (1) EP1019372B1 (enExample)
JP (1) JP2000503321A (enExample)
KR (1) KR100490108B1 (enExample)
CN (1) CN1209805A (enExample)
AP (1) AP1015A (enExample)
AT (1) ATE322480T1 (enExample)
AU (1) AU1746697A (enExample)
BG (1) BG102634A (enExample)
BR (1) BR9707051A (enExample)
CA (1) CA2243317C (enExample)
CZ (1) CZ215498A3 (enExample)
DE (1) DE69735647T2 (enExample)
ES (1) ES2263170T3 (enExample)
HU (1) HUP9901018A3 (enExample)
IL (1) IL125391A (enExample)
IS (1) IS4798A (enExample)
MX (1) MX9805701A (enExample)
NO (1) NO312670B1 (enExample)
NZ (1) NZ330861A (enExample)
OA (1) OA10811A (enExample)
PL (1) PL327936A1 (enExample)
RU (1) RU2167151C2 (enExample)
SK (1) SK94398A3 (enExample)
UA (1) UA49001C2 (enExample)
WO (1) WO1997026243A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750702A (en) * 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
US6211365B1 (en) 1996-01-19 2001-04-03 Neurogen Corporation Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
EP0888300A1 (en) 1996-03-22 1999-01-07 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands
US5723462A (en) * 1996-04-26 1998-03-03 Neurogen Corporation Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands
GT199800179A (es) * 1997-11-13 2000-05-02 Procedimiento de sintesis de pirrol amidas.
EA002243B1 (ru) * 1997-11-13 2002-02-28 Пфайзер Продактс Инк. Способ синтеза пирроламидов
US6156898A (en) * 1998-02-26 2000-12-05 Neurogen Corporation Substituted 1,4-dihydro-4-oxonicotinic carboxamides; GABA brain receptor ligands
GB9812038D0 (en) 1998-06-04 1998-07-29 Merck Sharp & Dohme Therapeutic compound
WO2000012492A1 (en) * 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
US20050014939A1 (en) * 1999-08-31 2005-01-20 Neurogen Corporation Fused pyrrolecarboxamides: GABA brain receptor ligands
EE200200111A (et) * 1999-08-31 2003-06-16 Neurogen Corporation Kondenseerunud pürroolkarboksamiidid: aju GABA-retseptori ligandid
US6723332B2 (en) 2000-05-26 2004-04-20 Neurogen Corporation Oxomidazopyridine-carboxamides
MXPA03001951A (es) * 2000-09-06 2003-10-15 Neurogen Corp Pirroliminas y pirazoliminas fusionadas substituidas.
BR0113697A (pt) * 2000-09-06 2003-07-22 Neurogen Corp Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou sal, embalagem e métodos para, para alterar a atividade transdutora de sinal dos receptores de gabaa, para tratar ansiedade, depressão, um distúrbio do sono, ou demência de alzheimer, para demonstrar a presença dos receptores de gabaa em células ou amostras de tecido e para preparar um composto
MXPA03004939A (es) * 2000-12-04 2003-09-10 Pfizer Prod Inc Sintesis de pirrolamidas.
US6852730B2 (en) * 2002-02-07 2005-02-08 Neurogen Corporation Substituted fused pyrazolecarboxylic acid arylamides and related compounds
CA2486339A1 (en) * 2002-05-17 2003-11-27 Neurogen Corporation Substituted ring-fused imidazole derivates: gabaa receptor ligands
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
CA2666219C (en) 2006-10-16 2017-02-07 Bionomics Limited Novel anxiolytic compounds
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2789237A1 (en) 2010-08-31 2014-10-15 Meiji Seika Pharma Co., Ltd. Pest control agent
US9023848B2 (en) 2011-03-02 2015-05-05 Bionomics Limited Small-molecules as therapeutics
CN103649086A (zh) 2011-05-12 2014-03-19 生态学有限公司 制备萘啶的方法
CN120081825B (zh) * 2025-05-07 2025-09-16 天津匠新致成科技有限公司 一种化合物及其制备方法和医药用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455943A (en) * 1966-10-21 1969-07-15 American Cyanamid Co Certain 5,8-dihydro-beta-carbolines
US4075343A (en) * 1976-09-13 1978-02-21 Pfizer Inc. Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
DE3029980A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indolderivate und verfahren zu ihrer herstellung
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3147276A1 (de) * 1981-11-28 1983-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von indolderivaten, deren verwendung als wertvolle zwischenprodukte und neue 4-hydroxyindole
DE3246932A1 (de) * 1982-12-16 1984-06-20 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte 5h-pyrimido(5,4-b)indole
DE3335323A1 (de) * 1983-09-27 1985-04-04 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8429739D0 (en) * 1984-11-24 1985-01-03 Fbc Ltd Fungicides
DE3535927A1 (de) * 1985-10-04 1987-04-09 Schering Ag 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
JPH06502147A (ja) * 1990-10-09 1994-03-10 ニューロゲン　コーポレイション 或る種のシクロアルキルおよびアザシクロアルキルピロロピリミジン；新規な種類のｇａｂａ脳リセプタリガンド
US5243049A (en) * 1992-01-22 1993-09-07 Neurogen Corporation Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
WO1993017025A1 (en) * 1992-02-19 1993-09-02 The Upjohn Company 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity
US5266698A (en) * 1992-04-30 1993-11-30 Neurogen Corporation Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
WO1994017095A1 (en) * 1993-01-29 1994-08-04 Ariad Pharmaceuticals, Inc. Analogs of receptor tyrosine activation motifs and therapeutic uses thereof
FR2705095B1 (fr) * 1993-05-12 1995-06-23 Adir Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5484944A (en) * 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
RU2167151C2 (ru) 2001-05-20
WO1997026243A1 (en) 1997-07-24
DE69735647T2 (de) 2007-05-03
JP2000503321A (ja) 2000-03-21
NO983315L (no) 1998-09-03
AP1015A (en) 2001-09-28
UA49001C2 (uk) 2002-09-16
IS4798A (is) 1998-07-16
ATE322480T1 (de) 2006-04-15
AP9801297A0 (en) 1998-09-30
OA10811A (en) 2001-07-05
HUP9901018A3 (en) 1999-11-29
EP1019372B1 (en) 2006-04-05
DE69735647D1 (de) 2006-05-18
US5804686A (en) 1998-09-08
KR19990077300A (ko) 1999-10-25
CA2243317A1 (en) 1997-07-24
MX9805701A (es) 1998-11-30
SK94398A3 (en) 1999-02-11
ES2263170T3 (es) 2006-12-01
NO312670B1 (no) 2002-06-17
IL125391A (en) 2004-07-25
AU1746697A (en) 1997-08-11
EP1019372A1 (en) 2000-07-19
PL327936A1 (en) 1999-01-04
HUP9901018A2 (hu) 1999-07-28
US6080873A (en) 2000-06-27
CA2243317C (en) 2007-09-25
KR100490108B1 (ko) 2005-11-25
BG102634A (en) 1999-08-31
BR9707051A (pt) 1999-07-20
CZ215498A3 (cs) 1999-09-15
NZ330861A (en) 2000-03-27
NO983315D0 (no) 1998-07-17
IL125391A0 (en) 1999-03-12

Similar Documents

Publication Publication Date Title
CN1209805A (zh) 新型稠合的吡咯碳酰胺、新一类的gaba脑受体配位体
CN1034174C (zh) 咪唑并喹喔啉类γ-氨基丁酸脑受体配位体的制备方法
CN1143953A (zh) 某些稠合n-吡咯甲酰苯胺；一类新的脑gaba受体配体
CN1028104C (zh) 制备喹诺酮衍生物的方法
CN1077573C (zh) 用作神经激肽拮抗剂的杂环类化合物
CN1281590C (zh) 具有抑制血管生成活性的六员氨基酰胺类衍生物
CN1062269C (zh) 新型(r)-5-氨甲酰基-8-氟-3-n，n-二取代氨基-3，4-二氢-2h-1-苯并吡喃
CN1247571C (zh) 新颖的2h－哒嗪－3－酮衍生物、含有它们的药物组合物和活性成分的制备方法
CN1124960A (zh) 作为5-ht/a和/或5-ht2配体的吲哚衍生物
CN1260792A (zh) 选择性的雌激素受体调节剂用于治疗中枢神经系统疾病
CN1886393A (zh) 含有环烷基或吡喃基基团的atp－结合弹夹转运蛋白的调控剂
CN101052641A (zh) 6H－[1]苯并吡喃并[4,3－b]喹啉及其作为雌激素药物的用途
CN1662497A (zh) N－[苯基(哌啶－2－基)甲基]苯甲酰胺衍生物,其制备方法及其在治疗中的应用
CN1074764C (zh) 苯并噁嗪酮多巴胺d4受体拮抗剂
CN1234023A (zh) 作为多巴胺d2激动剂和5ht1a的配位体的4－氨基乙氧基吲哚
CN1608065A (zh) 苯基取代的三唑及其作为选择性alk5激酶抑制剂的用途
CN1040979C (zh) 抑制精神活动的方法
CN1059441C (zh) 苯并吡喃醇类化合物、其制法及其药物组合物与用途
CN1032440A (zh) 4-氨基吡啶衍生物类
CN1681783A (zh) 2,4－取代吲哚和它们作为5－ht6调节剂的用途
CN1348451A (zh) 治疗抑郁症的氮杂吲哚衍生物
CN1890227A (zh) 苯并噁嗪衍生物及其用途
CN1325397A (zh) 2－哌嗪烷基氨基苯并吡咯衍生物∶多巴胺受体亚型特异配体
CN1063177C (zh) 治疗偏头痛的吲哚烷基－吡啶基和嘧啶基哌嗪的1,2,5－噻二唑衍生物
JP2008115175A (ja) 複素環化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1018455

Country of ref document: HK